March 30th- Dr. Andres Ramirez Gamero- Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia

CME Congresses .

March 30th- Dr. Andres Ramirez Gamero- Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia

March 23rd- Zanubrutinib in High-Risk CLL: Changing the Prognosis of del(17p)/TP53 Disease

CME Congresses .

March 23rd- Zanubrutinib in High-Risk CLL: Changing the Prognosis of del(17p)/TP53 Disease

March 19th- Beyond the webinar: CAR-T Cell Therapy: Are We Entering a New Therapeutic Era?

CME Congresses .

March 19th- Beyond the webinar: CAR-T Cell Therapy: Are We Entering a New Therapeutic Era?

March 17th- Beyond the webinar: CARTITUDE-4 long-term follow-up: Is early CAR-T changing the natural history of relapsed myeloma?

CME Congresses .

March 17th- Beyond the webinar: CARTITUDE-4 long-term follow-up: Is early CAR-T changing the natural history of relapsed myeloma?

March 16th- Belumosudil vs Best Available Therapy in cGVHD: Real-World Evidence That Matters

CME Congresses .

March 16th- Belumosudil vs Best Available Therapy in cGVHD: Real-World Evidence That Matters

March 12th- Beyond the webinar: Supportive Care in Chronic GVHD- Beyond Immunosuppression

CME Congresses .

March 12th- Beyond the webinar: Supportive Care in Chronic GVHD- Beyond Immunosuppression

March 9th- Dr. David Scott- Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology

CME Congresses .

March 9th- Dr. David Scott- Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology

March 4th- TP53-mutated CLL in the very elderly: choosing the least harmful effective sequence

CME Congresses .

March 4th- TP53-mutated CLL in the very elderly: choosing the least harmful effective sequence

March 2nd- Dr. Rahul Banerjee- Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data

CME Congresses .

March 2nd- Dr. Rahul Banerjee- Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data

February 26th- Extramedullary Disease in Multiple Myeloma: Biology, Treatment, and the Road Ahead

CME Congresses .

February 26th- Extramedullary Disease in Multiple Myeloma: Biology, Treatment, and the Road Ahead